Rules
Aboutfair balancerisk disclosureindication on labelsubstantiationcomparativemisleading presentationname ingredientsubmissionpre approvalscientific exchangedisclosure
Naturepromotional
Document typeadvertisement
Risk info placementdistinct-part
Communication typeadvertisement
Regulatory classprescription-drug
Drug classprescription
Rx statusprescription
Advertising typeprescription-drug-advertisement
Populationhuman-use
Content triggerliterature-or-study-effectiveness-claim
Materialadvertisement
Content typeadvertisement
Active ingredient counttwo-or-more
Proprietary name basismixture-designation
Established name statusnone-for-mixture-designation
Drug classificationprescription
Labeling scenariosingle-proprietary-name-multiple-preparations-no-established-name
Prescription statusprescription-drug
Ad formattelevision
Intended specieshuman
Exemption statusnon-exempt
Approval pathwayaccelerated
4 of 251 rules — including rules the source does not limit to any one scope
US-DISC-001·Q.8/A.8, bullet 1AI-verified
Accurately represent study results relied upon
warningneeds human judgment
US-DISC-002·Q.8/A.8, bullet 1AI-verified
Disclose material study design/methodology factors
warningneeds human judgment
US-DISC-003·Q.8/A.8, bullet 1AI-verified
Disclose material limitations of study design, methodology, and results
warningneeds human judgment
US-DISC-004·Section VI, Recommendation 3AI-verified
Firm representatives should disclose their firm affiliation in public responses
warningcheckable